Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

Flixotide Inhaler

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

76 API Suppliers, 30 USDMF, 30 CEP/COS, 6 JDMF, 6 EU WC, 2 KDMF, 26 NDC API, 45 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

54 Drugs in Development

54 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

455 FDF Dossiers, 71 FDA Orange Book, 212 Europe, 32 Canada, 22 Australia, 51 South Africa, 67 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY, SPRAY, METERED;NASAL - 0.05MG/SPRAY, POWDER;INHALATION - 0.05MG/INH, POWDER;INHALATION - 0.1MG/INH, POWDER;INHALATION - 0.25MG/INH, POWDER;INHALATION - 0.03MG/INH, POWDER;INHALATION - 0.055MG/INH, POWDER;INHALATION - 0.113MG/INH, POWDER;INHALATION - 0.232MG/INH, POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH, POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH, POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH, LOTION;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH, AEROSOL, METERED;INHALATION - 0.044MG/INH, AEROSOL, METERED;INHALATION - 0.11MG/INH, AEROSOL, METERED;INHALATION - 0.22MG/INH

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Rochem International Inc, 2 SPI Pharma, 3 DKSH, 2 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 10 Actylis, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 11 BASF, 5 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 20 Kerry, 1 Kima Chemical, 10 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 10 Roquette, 8 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 Silverline Chemicals, 1 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

37 Fillers, Diluents & Binders, 22 Thickeners and Stabilizers, 21 Solubilizers, 19 Topical, 16 Direct Compression, 14 Disintegrants & Superdisintegrants, 13 Parenteral, 12 Granulation, 10 Co-Processed Excipients, 10 Emulsifying Agents, 9 Controlled & Modified Release, 8 Rheology Modifiers, 7 Film Formers & Plasticizers, 6 Coating Systems & Additives, 6 Surfactant & Foaming Agents, 3 Taste Masking, 2 Chewable & Orodispersible Aids, 1 Lubricants & Glidants, 1 API Stability Enhancers

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 142 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 164 Regulatory FDF Prices, 12 Annual Reports

MARKET PLACE

16 APIs, 5 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

523 US Patents, 11 US Exclusivities, 53 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 8 USP, 9 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
04/06/2025	EUROAPI	France	EUROAPI FRANCE Vertolaye FR	R1-CEP 2018-040 - Rev 00	Fluticasone propionate, Non-micronised, micronised	2023-05-03	Valid	Chemical		1750
04/06/2025	Coral Drugs Private Limited	India	CORAL DRUGS PRIVATE LIMITED New Delhi IN	R0-CEP 2021-492 - Rev 00	Fluticasone propionate, Process 1	2023-06-01	Valid	Chemical		1750

Flixotide Inhaler

Flixotide Inhaler

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

76 API Suppliers

30 USDMF

30 CEP/COS

6 JDMF

6 EU WC

2 KDMF

26 NDC API

45 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

54 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

455 FDF Dossiers

71 FDA Orange Book

212 Europe

32 Canada

22 Australia

51 South Africa

67 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SPRAY, METERED;NASAL - 0.137MG/SPRAY;0.05MG/SPRAY

SPRAY, METERED;NASAL - 0.05MG/SPRAY

POWDER;INHALATION - 0.05MG/INH

POWDER;INHALATION - 0.1MG/INH

POWDER;INHALATION - 0.25MG/INH

POWDER;INHALATION - 0.03MG/INH

POWDER;INHALATION - 0.055MG/INH

POWDER;INHALATION - 0.113MG/INH

POWDER;INHALATION - 0.232MG/INH

POWDER;INHALATION - 0.055MG/INH;EQ 0.014MG BASE/INH

POWDER;INHALATION - 0.113MG/INH;EQ 0.014MG BASE/INH

POWDER;INHALATION - 0.232MG/INH;EQ 0.014MG BASE/INH

POWDER;INHALATION - 0.1MG/INH;EQ 0.05MG BASE/INH

POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH

POWDER;INHALATION - 0.5MG/INH;EQ 0.05MG BASE/INH

LOTION;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - 0.045MG/INH;EQ 0.021MG BASE/INH

AEROSOL, METERED;INHALATION - 0.115MG/INH;EQ 0.021MG BASE/INH

AEROSOL, METERED;INHALATION - 0.23MG/INH;EQ 0.021MG BASE/INH

AEROSOL, METERED;INHALATION - 0.044MG/INH

AEROSOL, METERED;INHALATION - 0.11MG/INH

AEROSOL, METERED;INHALATION - 0.22MG/INH

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Rochem International Inc

2 SPI Pharma

3 DKSH

2 Faran Shimi Pharmaceutical

4 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

10 Actylis

3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

11 BASF

5 DFE Pharma

2 Finar

7 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

1 Ingredion Pharma Solutions

20 Kerry

1 Kima Chemical

10 Microlex e.U

1 Nanjing Bold Chemical

1 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Chemical

10 Roquette

8 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

OINTMENT;TOPICAL - 0.005% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - 0.05MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

LOTION;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons